Stem Cell-Related Stocks on the Move Following Cytori News (CYTX, STEM, PSTI, ASTM)
Stem cell-related stocks are active this morning following news out of Cytori Therapeutics (Nasdaq: CYTX) that a recent study has suggested adipose tissue-derived stem and regenerative cells significantly reduce mortality and improve renal function in an acute kidney injury model.
Shares of Cytori are currently up about 4% to $3.22.
The news should be positive for the stem cell sector as a whole. Other stocks to watch on this news: StemCells (Nasdaq: STEM), Pluristem Therapeutics (Nasdaq: PSTI) and Aastrom Biosciences (Nasdaq: ASTM).
Related Categories
Corporate NewsInsiders' Blog
Momentum Movers
Stocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
